JAC对 antimicrobial stewardship 的贡献
本文为纪念《Journal of Antimicrobial Chemotherapy》(JAC)创刊40周年而撰写,回顾了JAC在抗菌药物管理(antimicrobial stewardship)领域的贡献。文章指出抗菌药物管理项目旨在优化临床结局并减少耐药性的产生与传播,JAC发表的论文为管理提供了证据基础,并强调了旨在改善抗生素处方实践的教育与行为改变举措。
要点
- JAC发表论文为抗菌药物管理提供了证据基础。
- JAC强调了改善抗生素处方实践的教育与行为改变举措。
- JAC积极在读者中推广抗菌药物管理实践。
核心结论
- JAC通过发表相关论文、强调教育行为改变和推广实践,对抗菌药物管理作出了贡献。
研究设计与样本
- 本文为纪念JAC创刊40周年的回顾性文章,未报告系统检索方法或样本量。
主要发现
- JAC发表的论文为抗菌药物管理提供了证据基础。
- JAC强调了旨在改善抗生素处方实践的教育与行为改变举措。
- JAC积极在读者中推广抗菌药物管理实践。
临床怎么用
- 临床医生可关注JAC发表的抗菌药物管理相关证据,以优化处方实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antimicrobial stewardship programmes are increasingly being used to improve the quality of antimicrobial prescribing, with the dual aim of optimizing clinical outcomes and minimizing the emergence and spread of antimicrobial resistance. The Journal of Antimicrobial Chemotherapy (JAC) is celebrating its 40th anniversary and, as part of activities to commemorate this event, this article highlights the contribution of JAC to antimicrobial stewardship. Papers published in JAC have contributed to the evidence base for stewardship, have highlighted educational and behavioural change initiatives aimed at improving antibiotic prescribing practice, and have actively sought to foster the practice of antimicrobial stewardship amongst its readers.
引用
- Johnson AP. Contribution of JAC to antimicrobial stewardship. J Antimicrob Chemother. 2016. PMID: 27880718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。